Whither HER2-related therapeutics?
De
Pradip
P
Leyland-Jones
Brian
B
D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis / Q000037:antagonists & inhibitors* / Q000502:physiology; D020893:Receptor, ErbB-3 / Q000032:analysis / Q000502:physiology
D018719:Erb-b2 Receptor Tyrosine Kinases; D020893:Receptor, ErbB-3; C508053:ERBB2 protein, human